Regenxbio (RGNX) Accumulated Expenses (2014 - 2026)
Regenxbio's Accumulated Expenses came in at $23.07 million for Q2 2026, down 35.1% from $35.56 million a year earlier but up 5.4% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Accumulated Expenses was $38.39 million, up 0.8% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $38.07 million in FY2024 (-23.4%), $49.7 million in FY2023 (+6.2%), $46.79 million in FY2022 (-38.5%) and $76.11 million in FY2021 (+55.1%).
- The five-year range for quarterly Accumulated Expenses is $21.89 million (Q1 2026) to $76.11 million (Q4 2021).
- Year-over-year, Accumulated Expenses increased in two of the last eight quarters, with an average decline of 15.6%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2021 (growth of 55.1%), and the weakest in Q4 2022 (a decline of 38.5%).
- Business Quant data shows RGNX's Accumulated Expenses at $21.89 million (Q1 2026), $38.39 million (Q4 2025) and $38.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.61 Mn |
| Jun 30, 2026 | 23.07 Mn |
| Mar 31, 2026 | 21.89 Mn |
| Dec 31, 2025 | 38.39 Mn |
| Sep 30, 2025 | 38.32 Mn |
| Jun 30, 2025 | 35.56 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 38.07 Mn |
| Sep 30, 2024 | 48.64 Mn |
| Jun 30, 2024 | 42.49 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Dec 31, 2023 | 49.70 Mn |
| Sep 30, 2023 | 45.66 Mn |
| Jun 30, 2023 | 50.52 Mn |
| Mar 31, 2023 | 31.71 Mn |
| Dec 31, 2022 | 46.79 Mn |
| Sep 30, 2022 | 44.46 Mn |
| Jun 30, 2022 | 47.01 Mn |
| Mar 31, 2022 | 48.42 Mn |
| Dec 31, 2021 | 76.11 Mn |
API Access
Regenxbio Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();